Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zeria Pharmaceutical Co's total inventories for the quarter that ended in Mar. 2026 was 円20,897 Mil. Zeria Pharmaceutical Co's average total inventories from the quarter that ended in Dec. 2025 to the quarter that ended in Mar. 2026 was 円20,920 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Zeria Pharmaceutical Co's Net-Net Working Capital per share for the quarter that ended in Mar. 2026 was 円-216.26.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Zeria Pharmaceutical Co's Days Inventory for the
three
months ended in Mar. 2026 was 296.85.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Zeria Pharmaceutical Co's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.31.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Zeria Pharmaceutical Co's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.83.
Zeria Pharmaceutical Co (TSE:4559) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Zeria Pharmaceutical Co's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2026 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Zeria Pharmaceutical Co's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Zeria Pharmaceutical Co Total Inventories Related Terms
Zeria Pharmaceutical Co Total Inventories Historical Data
* Premium members only.
The historical data trend for Zeria Pharmaceutical Co's Total Inventories can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zeria Pharmaceutical Co Total Inventories Calculation
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
What does a Total Inventories of 円20,897 Mil mean?
Zeria Pharmaceutical Co (TSE:4559) has a Total Inventories of 円20,897 Mil as of Mar. 2026. The total amount of inventory as recorded on a company's balance sheet. View historical data for Zeria Pharmaceutical Co and its competitors.
Is Zeria Pharmaceutical Co's Total Inventories too high?
Zeria Pharmaceutical Co's current Total Inventories is 円20,897 Mil. Overall, Zeria Pharmaceutical Co has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zeria Pharmaceutical Co's Total Inventories compare to ZTS and UTHR?
Zeria Pharmaceutical Co's Total Inventories of 円20,897 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Drug Manufacturers company?
A good Total Inventories depends on the Drug Manufacturers industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Zeria Pharmaceutical Co and its competitors. Zeria Pharmaceutical Co's current Total Inventories is 円20,897 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zeria Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zeria Pharmaceutical Co (TSE:4559) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,506.68, compared to a current price of 円2,087.00 — trading 16.7% below its estimated fair value. The current Total Inventories is 円20,897 Mil. Zeria Pharmaceutical Co's overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Zeria Pharmaceutical Co (TSE:4559), the current Total Inventories is 円20,897 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zeria Pharmaceutical Co (TSE:4559) Overvalued in 2026?
Based on GuruFocus' analysis, Zeria Pharmaceutical Co stock appears to be undervalued.
The current stock price of 円2,087.00 is trading 16.7% below its estimated GF Value™ of 円2,506.68.
GuruFocus considers Zeria Pharmaceutical Co to be Modestly Undervalued.
Key valuation signals for TSE:4559:
Total Inventories: 円20,897 Mil
GF Value™: 円2,506.68 vs. price of 円2,087.00 (16.7% below fair value)
No single metric tells the full story. See the TSE:4559 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zeria Pharmaceutical Co Ltd is a Japanese pharmaceutical company. The company through its subsidiaries engages in two business divisions which include ethical pharmaceutical products and consumer healthcare products business division. It principally manufactures, sells, imports and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, reagents, cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, and health equipment.
85GF Score
Get the complete analysis for TSE:4559
Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4559 has been successfully added to your 
